Jerzy Bełtowski Selected Research

endothelium-dependent hyperpolarization factor (EDHF)

1/2014	Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide.
2/2012	Leptin and the regulation of endothelial function in physiological and pathological conditions.
10/2009	Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome.
5/2006	Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerzy Bełtowski Research Topics

Disease

22	Obesity 01/2022 - 06/2002
22	Hypertension (High Blood Pressure) 01/2021 - 01/2003
13	Atherosclerosis 01/2019 - 03/2002
11	Insulin Resistance 01/2022 - 02/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2008
4	Hypertrophy 09/2018 - 01/2003
4	Type 2 Diabetes Mellitus (MODY) 09/2018 - 02/2003
4	Neoplasms (Cancer) 09/2018 - 12/2007
3	Hyperhomocysteinemia 01/2020 - 07/2004
3	Heart Failure 09/2018 - 06/2006
3	Diabetes Mellitus 01/2018 - 06/2006
3	Dyslipidemias (Dyslipidemia) 01/2017 - 01/2008
3	Fatty Liver 01/2017 - 12/2007
3	Hyperlipidemias (Hyperlipidemia) 01/2017 - 06/2006
3	Hyperinsulinism (Hyperinsulinemia) 11/2013 - 06/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2012 - 03/2004
3	Hypoxia (Hypoxemia) 08/2010 - 03/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2008 - 02/2003
2	Fibrosis (Cirrhosis) 10/2019 - 09/2018
2	Diabetic Angiopathies (Diabetic Angiopathy) 01/2019 - 01/2017
2	Inflammation (Inflammations) 01/2018 - 03/2004
2	Body Weight (Weight, Body) 02/2010 - 03/2004
2	Essential Hypertension 03/2008 - 05/2006
1	Disease Progression 01/2020
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Multiple Sclerosis 01/2020
1	Weight Loss (Weight Reduction) 05/2019
1	Endometrial Neoplasms (Endometrial Cancer) 09/2018
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Osteoporosis 11/2016
1	Diabetes Complications 10/2016
1	Vascular Remodeling 01/2014
1	Edema (Dropsy) 01/2013
1	Reperfusion Injury 07/2012
1	Hyperglycemia 07/2010

Drug/Important Bio-Agent (IBA)

21	LeptinIBA 01/2014 - 06/2002
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2003
6	AntioxidantsIBA 01/2020 - 01/2002
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2018 - 12/2003
6	Insulin (Novolin)FDA Link 09/2018 - 06/2006
5	EnzymesIBA 05/2019 - 01/2004
5	SodiumIBA 01/2014 - 03/2004
5	Hormones (Hormone)IBA 02/2012 - 06/2006
5	Fatty Acids (Saturated Fatty Acids)IBA 12/2011 - 02/2003
5	Adenosine Triphosphatases (ATPase)IBA 02/2010 - 06/2002
4	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 08/2010
4	HomocysteineIBA 01/2020 - 07/2004
4	Aryldialkylphosphatase (Paraoxonase)IBA 09/2018 - 01/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2003
4	AdipokinesIBA 01/2018 - 06/2006
4	endothelium-dependent hyperpolarization factor (EDHF)IBA 01/2014 - 05/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012 - 03/2002
3	CholesterolIBA 01/2010 - 03/2002
3	Triglycerides (Triacylglycerol)IBA 01/2008 - 02/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2007 - 10/2003
2	Glycerol (Glycerine)FDA LinkGeneric 01/2022 - 12/2011
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 12/2011
2	Metformin (Glucophage)FDA LinkGeneric 09/2018 - 10/2016
2	homocysteine thiolactoneIBA 09/2018 - 11/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014 - 02/2008
2	Rosiglitazone (Avandia)FDA Link 11/2013 - 01/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 01/2003
2	ResistinIBA 03/2008 - 02/2003
2	AdiponectinIBA 03/2008 - 02/2003
2	Lipoproteins (Lipoprotein)IBA 03/2008 - 10/2002
2	Transcription Factors (Transcription Factor)IBA 01/2008 - 12/2007
2	Ouabain (G Strophanthin)IBA 04/2007 - 01/2004
2	sodium-translocating ATPase (ATPase, sodium)IBA 04/2007 - 01/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2005 - 07/2004
2	AcidsIBA 01/2004 - 10/2003
1	polysulfideIBA 01/2022
1	AldosteroneIBA 01/2021
1	SaltsIBA 01/2021
1	Neuroprotective AgentsIBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Exenatide (Byetta)FDA Link 05/2019
1	Advanced Glycation End ProductsIBA 09/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2018
1	ProgranulinsIBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 11/2016
1	HDL LipoproteinsIBA 11/2016
1	Bone Density Conservation AgentsIBA 11/2016
1	EsterasesIBA 11/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014
1	EndocannabinoidsIBA 11/2013
1	ThiazolidinedionesIBA 01/2013
1	Pioglitazone (Actos)FDA Link 01/2013
1	Atorvastatin (Lipitor)FDA Link 12/2011
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2011
1	Vitamin D FDA LinkGeneric 12/2011
1	Cholecalciferol (Vitamin D3)FDA Link 12/2011
1	phenyl acetateIBA 07/2010
1	Paraoxon (E600)IBA 07/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2010
1	GonadotropinsIBA 01/2010

Therapy/Procedure

2	Therapeutics 01/2019 - 04/2008
1	Highly Active Antiretroviral Therapy (HAART) 11/2016